The Community Focus Channel is supported with funding from Johnson & Johnson (Gold).
The Non-Malignant Channel is supported with funding from Agios (Gold).
The Thalassemia Channel is supported with funding from Agios (Gold).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESH Erythro 2025 | Key challenges that exist when treating adults with thalassemia & important factors to consider
In this video, Perla Eleftheriou, MRCP, FRCpath, University College London Hospitals NHS Foundation Trust, London, UK, shares insights into the challenges faced when treating adult patients with thalassemia, highlighting the heterogeneity of care depending on resources, location, and tools available. Dr Eleftheriou emphasizes the difficulties of managing chronic blood transfusions, iron overload, and their complications, as well as the need for a dedicated thalassemia team. She also stresses the importance of addressing mental health struggles and quality of life concerns in these patients, which are often inadequately supported. This interview took place at the 4th ESH Translational Research Conference on Pathophysiology and Clinical Advances in Sickle Cell Disease and Thalassemia in Dublin, Ireland.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
